Skip to Main Content

Paper Details

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma.
Blood Adv
29
2020
B-cell maturation antigen, BCMA, BCMA-targeted CAR-T cells, CAR-T cells, Cancer, Cancer cells, HDAC7, Sec61, Sec61 complex, cancer, cancer cells, chimeric, chimeric antigen receptor T cells, multiple myeloma, myeloma, myeloma cells, primary patient cells
Author NameAffiliation
Jack Taunton
Arun P WiitaUniversity of California san francisco
Arun P WiitaHelen Diller Family Comprehensive Cancer Center.
Arun P WiitaUniversity of California san francisco
Arun P WiitaHelen Diller Family Comprehensive Cancer Center.
Martin KampmannInstitute for Neurodegenerative Diseases and.
Martin Kampmann
Martin KampmannHelen Diller Family Comprehensive Cancer Center.
Martin KampmannUniversity of California san francisco
  • 1 - 9

Datasets

Release 1.2